
Australis Capital Inc. (OTCQB:AUSAF) (CSE:AUSA) released its unaudited results for its fiscal year ended March 31, 2022, revealing revenue increased by over 1,200% to nearly CA$9.5 million ($7.38 million), driven predominantly by a full year of ALPS revenue consolidated, as well as growth in the ALPS business throughout the year, along with management fee income starting in fiscal '22 related to the Green Therapeutics ("GT") business.
Fiscal Year 2022 Financial Highlights